Pancreatic Cancer Research

ResearcherNuvox Pharma, LlcNo recent work listed

Evan charles Unger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8327-7731; OpenAlex author ID A5070747321; NIH RePORTER profile ID 9356312. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
2
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 grant · 2017: none · 2018: none · 2019: 1 grant · 2020: 1 paper · 2021: 1 paper

Papers 2

  1. Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer. Co-author DOI 10.1002/btm2.10183↗
  2. Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/rli.0000000000000697↗

Grants 2

  1. Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development R44CA203090↗
  2. Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development R41CA203090↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sanjiv Sam Gambhir · 1 shared paper, 1 shared grant, 2019–2020 · strength 0.51
  2. Rakesh Bam · 2 shared papers, 2020–2021 · strength 0.28
  3. Ramasamy Paulmurugan · 2 shared papers, 2020–2021 · strength 0.28
  4. Juergen Karl Willmann · 1 shared grant, 2016 · strength 0.25
  5. Natacha Jugniot · 1 shared paper, 2021 · strength 0.17
  6. Lotfi Abou‐Elkacem · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.